|
1
|
Mao HY, Liu SP, Kong GM, Xu Y, Xu YC, Sun GZ, Wang Z, Han F, Tong JD, Bo P. FBLN3 inhibited the invasion and metastasis of colorectal cancer through the AKT/mTOR pathway. Neoplasma 2019; 66:336-342. [PMID: 30784281 DOI: 10.4149/neo_2018_180703n441] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2018] [Accepted: 10/29/2018] [Indexed: 11/08/2022]
Abstract
Fibulin-3(FBLN3) levels are different in different types of cancers. We found that fibulin-3 was downregulated in colorectal (CRC) cells, particularly in the SW480 cell line. By comparison, transfecting SW480 cells with a lentivirus overexpressing fibulin-3 RNA could inhibit proliferation, induce G1/S arrest, and promote cell apoptosis. Fibulin-3 overexpression further suppressed the invasion and metastasis of CRC. These effects were regulated through the AKT/mTOR signaling pathway.
Collapse
Affiliation(s)
- H Y Mao
- Department of Oncology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China.,Medical College of Yangzhou University, Yangzhou University, Yangzhou, China
| | - S P Liu
- Yangzhou Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Yangzhou, China
| | - G M Kong
- Medical College of Yangzhou University, Yangzhou University, Yangzhou, China
| | - Y Xu
- Department of Oncology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China
| | - Y C Xu
- Department of Oncology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China
| | - G Z Sun
- Medical College of Yangzhou University, Yangzhou University, Yangzhou, China
| | - Z Wang
- Department of Oncology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China
| | - F Han
- Department of Oncology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China
| | - J D Tong
- Department of Oncology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China
| | - P Bo
- Medical College of Yangzhou University, Yangzhou University, Yangzhou, China
| |
Collapse
|